Jim Simons Hoth Therapeutics, Inc. Transaction History

Renaissance Technologies LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.36 - $9.25 $7,632 - $196,100	-21,200 Reduced 13.48%	136,045 $47,000
Q2 2022 Aug 12, 2022	BUY	$0.38 - $1.05 $26,161 - $72,287	68,845 Added 77.88%	157,245 $66,000
Q1 2022 May 13, 2022	SELL	$0.52 - $1.3 $40,924 - $102,310	-78,700 Reduced 47.1%	88,400 $61,000
Q4 2021 Feb 11, 2022	BUY	$0.66 - $1.18 $110,286 - $197,178	167,100 New	167,100 $110,000
Q2 2021 Aug 13, 2021	SELL	$1.31 - $2.14 $289,510 - $472,940	-221,000 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$1.85 - $3.04 $118,048 - $193,982	63,810 Added 40.59%	221,000 $435,000
Q4 2020 Feb 10, 2021	BUY	$1.58 - $2.37 $123,211 - $184,817	77,982 Added 98.45%	157,190 $373,000
Q3 2020 Nov 13, 2020	BUY	$1.86 - $3.15 $103,155 - $174,699	55,460 Added 233.54%	79,208 $156,000
Q2 2020 Aug 13, 2020	BUY	$2.53 - $4.08 $60,082 - $96,891	23,748 New	23,748 $61,000

Ticker HOTH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,288,470
Market Cap $1.06M
Description
Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs. It is involved in the development of HT-001, a topical formulation for the treatment of patients with rash and skin disorders associated with initial and repeat courses of tyrosine kinase epidermal growth factor receptor ...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.